These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 17566705

  • 1. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
    Scheper MA, Nikitakis NG, Sauk JJ.
    Int J Oral Maxillofac Surg; 2007 Jul; 36(7):632-9. PubMed ID: 17566705
    [Abstract] [Full Text] [Related]

  • 2. COX-independent antineoplastic effects of sulindac in oral cancer are mediated by survivin down-regulation.
    Scheper MA, Sauk JJ, Nikitakis NG.
    Anticancer Res; 2006 Jul; 26(6B):4103-13. PubMed ID: 17201121
    [Abstract] [Full Text] [Related]

  • 3. The nonsteroidal anti-inflammatory drug sulindac causes down-regulation of signal transducer and activator of transcription 3 in human oral squamous cell carcinoma cells.
    Nikitakis NG, Hamburger AW, Sauk JJ.
    Cancer Res; 2002 Feb 15; 62(4):1004-7. PubMed ID: 11861373
    [Abstract] [Full Text] [Related]

  • 4. The oncogenic effects of constitutive Stat3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac.
    Nikitakis NG, Scheper MA, Papanikolaou VS, Sauk JJ.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jun 15; 107(6):826-36. PubMed ID: 19272804
    [Abstract] [Full Text] [Related]

  • 5. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
    Gu L, Chiang KY, Zhu N, Findley HW, Zhou M.
    Exp Hematol; 2007 Jun 15; 35(6):957-66. PubMed ID: 17533050
    [Abstract] [Full Text] [Related]

  • 6. Sulindac induces apoptosis and inhibits tumor growth in vivo in head and neck squamous cell carcinoma.
    Scheper MA, Nikitakis NG, Chaisuparat R, Montaner S, Sauk JJ.
    Neoplasia; 2007 Mar 15; 9(3):192-9. PubMed ID: 17401459
    [Abstract] [Full Text] [Related]

  • 7. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin.
    Jin HO, Yoon SI, Seo SK, Lee HC, Woo SH, Yoo DH, Lee SJ, Choe TB, An S, Kwon TJ, Kim JI, Park MJ, Hong SI, Park IC, Rhee CH.
    Biochem Pharmacol; 2006 Nov 15; 72(10):1228-36. PubMed ID: 16950207
    [Abstract] [Full Text] [Related]

  • 8. Deguelin suppresses cell proliferation via the inhibition of survivin expression and STAT3 phosphorylation in HTLV-1-transformed T cells.
    Ito S, Oyake T, Murai K, Ishida Y.
    Leuk Res; 2010 Mar 15; 34(3):352-7. PubMed ID: 19781773
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
    Liu B, Shi ZL, Feng J, Tao HM.
    Cell Biol Int; 2008 May 15; 32(5):494-501. PubMed ID: 18078766
    [Abstract] [Full Text] [Related]

  • 11. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells.
    Kanda N, Seno H, Konda Y, Marusawa H, Kanai M, Nakajima T, Kawashima T, Nanakin A, Sawabu T, Uenoyama Y, Sekikawa A, Kawada M, Suzuki K, Kayahara T, Fukui H, Sawada M, Chiba T.
    Oncogene; 2004 Jun 17; 23(28):4921-9. PubMed ID: 15077160
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y.
    Cancer; 2006 Aug 15; 107(4):746-56. PubMed ID: 16826583
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines.
    Sumita N, Bito T, Nakajima K, Nishigori C.
    Exp Dermatol; 2006 Apr 15; 15(4):291-9. PubMed ID: 16512876
    [Abstract] [Full Text] [Related]

  • 17. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
    Masuda M, Suzui M, Yasumatu R, Nakashima T, Kuratomi Y, Azuma K, Tomita K, Komiyama S, Weinstein IB.
    Cancer Res; 2002 Jun 15; 62(12):3351-5. PubMed ID: 12067972
    [Abstract] [Full Text] [Related]

  • 18. Combined effects of sulindac and suberoylanilide hydroxamic acid on apoptosis induction in human lung cancer cells.
    Seo SK, Jin HO, Lee HC, Woo SH, Kim ES, Yoo DH, Lee SJ, An S, Rhee CH, Hong SI, Choe TB, Park IC.
    Mol Pharmacol; 2008 Mar 15; 73(3):1005-12. PubMed ID: 18156316
    [Abstract] [Full Text] [Related]

  • 19. Curcumin inhibits constitutive STAT3 phosphorylation in human pancreatic cancer cell lines and downregulation of survivin/BIRC5 gene expression.
    Glienke W, Maute L, Wicht J, Bergmann L.
    Cancer Invest; 2010 Feb 15; 28(2):166-71. PubMed ID: 20121547
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells.
    Li S, Tong Q, Zhang W, Wang Q, Chen Z, Wu Q.
    Cancer Invest; 2008 May 15; 26(4):333-7. PubMed ID: 18443952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.